Literature DB >> 6894924

Studies on the oxidative half-reaction of xanthine oxidase.

R Hille, V Massey.   

Abstract

The oxidative half-reaction of xanthine oxidase is reexamined with regard to the generation of the superoxide anion. By using cytochrome c reduction to monitor superoxide, it is found that the stoichiometry of superoxide produced to enzyme reoxidized is 2:1, significantly greater than previously reported (Olson, J. S., Ballou, D. P., Palmer, G., and Massey, V. (1974) J. Biol. Chem. 249, 4350-4362). Furthermore, the kinetics of superoxide-dependent cytochrome c reduction exhibits a pronounced lag during the rapid phase of enzyme reoxidation and a limiting rate identical with that of the slow phase of enzyme reoxidation. This indicates that superoxide is generated only in the last steps of the sequential removal of reducing equivalents from the enzyme by molecular oxygen. Experiments with the two-electron-reduced enzyme indicate that it too produces two superoxide ions for each molecule of enzyme reoxidized, demonstrating that it is the last two electrons to leave the enzyme in the course of reoxidation that form superoxide. The sequential scheme for the oxidative half-reaction must therefore be 6 leads to 4 leads to 2 leads to 1 leads to 0, where the numbers reflect the number of reducing equivalents in each intermediate. Using this scheme, both enzyme reoxidation and cytochrome c reduction can be accurately simulated. Reasons for the different behavior of the two-electron-reduced xanthine oxidase compared to the six- and four-electron-reduced enzyme are discussed.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6894924

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

1.  Flavin-linked Erv-family sulfhydryl oxidases release superoxide anion during catalytic turnover.

Authors:  Vidyadhar N Daithankar; Wenzhong Wang; Joliene R Trujillo; Colin Thorpe
Journal:  Biochemistry       Date:  2011-12-16       Impact factor: 3.162

Review 2.  Are either or both hyperuricemia and xanthine oxidase directly toxic to the vasculature? A critical appraisal.

Authors:  Tuhina Neogi; Jacob George; Sushma Rekhraj; Allan D Struthers; Hyon Choi; Robert A Terkeltaub
Journal:  Arthritis Rheum       Date:  2012-02

3.  Role of hydrogen peroxide in the cytotoxicity of the xanthine/xanthine oxidase system.

Authors:  E M Link; P A Riley
Journal:  Biochem J       Date:  1988-01-15       Impact factor: 3.857

4.  NADPH oxidase plays a central role in cone cell death in retinitis pigmentosa.

Authors:  Shinichi Usui; Brian C Oveson; Sun Young Lee; Young-Joon Jo; Tsunehiko Yoshida; Akiko Miki; Katsuaki Miki; Takeshi Iwase; Lili Lu; Peter A Campochiaro
Journal:  J Neurochem       Date:  2009-05-30       Impact factor: 5.372

5.  Tautomerism of xanthine and alloxanthine: a model for substrate recognition by xanthine oxidase.

Authors:  B Hernández; M Orozco; F J Luque
Journal:  J Comput Aided Mol Des       Date:  1996-12       Impact factor: 3.686

6.  The mechanism of superoxide production by NADH:ubiquinone oxidoreductase (complex I) from bovine heart mitochondria.

Authors:  Lothar Kussmaul; Judy Hirst
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-08       Impact factor: 11.205

Review 7.  The mononuclear molybdenum enzymes.

Authors:  Russ Hille; James Hall; Partha Basu
Journal:  Chem Rev       Date:  2014-01-28       Impact factor: 60.622

8.  The potential for xanthine oxidase inhibition in the prevention and treatment of cardiovascular and cerebrovascular disease.

Authors:  Peter Higgins; Jesse Dawson; Matthew Walters
Journal:  Cardiovasc Psychiatry Neurol       Date:  2009-11-04

9.  Hydrogen peroxide is the major oxidant product of xanthine oxidase.

Authors:  Eric E Kelley; Nicholas K H Khoo; Nicholas J Hundley; Umair Z Malik; Bruce A Freeman; Margaret M Tarpey
Journal:  Free Radic Biol Med       Date:  2009-11-24       Impact factor: 7.376

10.  The role of urate and xanthine oxidase in vascular oxidative stress: future directions.

Authors:  Jacob George; Allan Struthers
Journal:  Ther Clin Risk Manag       Date:  2009-10-12       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.